Provided by Tiger Fintech (Singapore) Pte. Ltd.

Galectin Therapeutics

2.80
-0.0900-3.11%
Post-market: 2.800.00000.00%19:59 EDT
Volume:445.51K
Turnover:1.32M
Market Cap:177.22M
PE:-3.87
High:3.18
Open:2.89
Low:2.79
Close:2.89
Loading ...
Nov 26, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Nov 12, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 12, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Sep 27, 2019

Major Issues Report

Current report, item 5.08
Sep 17, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Aug 20, 2019

Correspondence

[Cover]Correspondence
Aug 09, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Aug 09, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 05, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Jul 25, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 12, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 05, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
May 28, 2019

Major Issues Report

Current report, items 8.01 and 9.01
May 10, 2019

[Supp]Public Prospectus

Filing under Securities Act Rules 163/433 of free writing prospectuses